NCT04218721 (InvolveMe) is a NA clinical trial of InvolveMe in Renal Transplant Recipients, sponsored by Oslo University Hospital.

Who is sponsoring NCT04218721?

NCT04218721 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT04218721?

Interventions in NCT04218721: InvolveMe.

What condition does NCT04218721 study?

NCT04218721 studies Renal Transplant Recipients, Non-functioning Pituitary Adenoma.

Is NCT04218721 still recruiting?

NCT04218721 is currently completed. Last updated 31 May 2025.

Last reviewed 2025-05-31 · How we verify

NCT04218721: InvolveMe

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementing eHealth Interventions Into Regular Clinical Practice

Completed NA Last updated 31 May 2025

What this trial tests

NA trial testing InvolveMe in Renal Transplant Recipients in 23 participants. Completed in 28 September 2020.

Timeline

24 April 2020

Primary endpoint
28 September 2020

28 September 2020

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	23
Start date	24 April 2020
Primary completion	28 September 2020
Estimated completion	28 September 2020
Sites	1 location across Norway

Drugs / interventions tested

InvolveMe

Conditions studied

Renal Transplant Recipients — all drugs for Renal Transplant Recipients →
Non-functioning Pituitary Adenoma — all drugs for Non-functioning Pituitary Adenoma →

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Renal Transplant Recipients or Non-functioning Pituitary Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose with this study is to test a digital patient-provider communication tool for symptom and needs management among patients with chronic health conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of a Digital Patient-Provider Communication Intervention to Support Shared Decision-Making in Chronic Health Care, InvolveMe: Pilot Study.
Seljelid B, Varsi C, Solberg Nes L, Øystese KA, et al · · 2022 · cited 8× · PMID 35389356 · DOI 10.2196/34738

Verify or expand the search:

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04218721 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 31 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04218721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing